ii Tech Focus: Broadcom, Palantir, Oracle
With US technology still a hot sector, ii’s head of investment brings you the latest news, most-bought tech stocks on the ii platform and upcoming results.
6th March 2026 12:09
by Victoria Scholar from interactive investor
Photo: Jonathan Raa/NurPhoto via Getty Images.
Cryptoassets are very high risk and you should be prepared to lose all your money before you invest
Broadcom
Shares in Broadcom Inc (NASDAQ:AVGO) surged after it reported fiscal Q1 earnings and revenue which beat analysts’ expectations. The US semiconductor firm issued a rosy Q2 outlook forecasting sales of around $22 billion (£16.5 billion), beating expectations with AI chip revenue expected to reach $10.7 billion.
Longer term, the company anticipates AI chip sales “in excess of $100 billion” in 2027 as it looks to play catch up with market leader NVIDIA Corp (NASDAQ:NVDA). It also announced plans to buy back shares of up to $10 billion this year. Broadcom has been making notable progress, with significant custom chip deals with both Anthropic and OpenAI.
- The Analyst: AI stocks, trusts and funds still worth buying
- Ian Cowie: are you braced for AI apocalypse or buying into AI optimism?
Broadcom enjoyed several price target upgrades this week including from Morgan Stanley and Raymond James. According to Refinitiv, there is a consensus buy recommendation on the stock with an average price target of $461.65.
20 most-bought tech stocks on the ii platform
Company | |
1 | |
2 | |
3 | Palantir Technologies Inc Ordinary Shares - Class A (NASDAQ:PLTR) |
4 | |
5 | |
6 | |
7 | |
8 | |
9 | |
10 | |
11 | |
12 | |
13 | |
14 | |
15 | |
16 | |
17 | |
18 | |
19 | |
20 |
Source: interactive investor, 2-4 March 2026.
Palantir
Palantir Technologies Inc Ordinary Shares - Class A (NASDAQ:PLTR) is the third most-bought tech stock on the ii platform so far this week, only behind Nvidia and Tesla Inc (NASDAQ:TSLA). Shares have been performing very well lately, rallying 14% over the past week.
The war in Iran and geopolitical unease has sparked demand for defence stocks as well as related businesses such as Palantir, which offers AI tools used for military purposes. Also, in a sign of confidence in the business, at the end of last week UBS raised the stock to a buy from neutral and Rosenblatt Securities initiated coverage with a buy rating.
According to Refinitiv, there is a consensus buy recommendation on the stock with a target price of $189.68, up around 25% from the current share price.
Week Ahead
Oracle earnings
Oracle Corp (NYSE:ORCL) prepares to deliver Q3 earnings after the market closes on Tuesday 10 March. Last quarter, the database software firm plunged on results day after Q2 revenue of $16.06 billion fell short of analysts’ expectations for $16.21 billion. Investors shrugged off strong adjusted earnings per share (EPS) which hit $2.26, beating expectations.
- Investing in themes: what investors need to know
- Sign up to our free newsletter for investment ideas, latest news and award-winning analysis
According to Refinitiv, Oracle is expected to report EPS of $1.71 on revenue of $16.9 billion. In December, Oracle outlined Q3 guidance for adjusted EPS of $1.70 to $1.74 and revenue growth of 19% to 21%. Focus will be on its cloud infrastructure revenue, software revenue as well as its forward guidance. Options markets are implying a significant move on results day of around 8-9%.
Shares are down over 20% so far this year, caught up in AI jitters and the recent software sell-off. However, analysts mostly remain optimistic towards the company. According to Refinitiv, there is a consensus buy recommendation on the stock with an average target price of $276.22, representing around 80% upside from the current share price. Oppenheimer raised the stock from perform to outperform in late February, suggesting the stock could be poised for a rebound.
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.